.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 3,998,966

« Back to Dashboard

Claims for Patent: 3,998,966

Title: Anti-inflammatory, analgesic, anti-pyretic and anti-pruritic 6-substituted 2-naphthyl acetic acid derivative-containing compositions and methods of use thereof
Abstract:2-Naphthyl acetic acid derivatives and the corresponding amides, esters, hydroxamic acids and addition salts thereof, optionally substituted at the .alpha.-position on the acetic acid moiety and/or at position 6 and/or at positions 1, 4, 7 or 8 on the naphthyl ring and optionally saturated at positions 3 and 4, are anti-inflammatory, analgesic, anti-pyretic and anti-pruritic agents. A pharmaceutical method of effecting treatment of inflammation, pain, pyrexia and pruritus by the administration of naphthyl acetic acid derivatives. A pharmaceutical composition for use in the treatment of the above maladies comprising a naphthyl acetic acid derivative.
Inventor(s): Fried; John H. (Palo Alto, CA), Harrison; Ian T. (Palo Alto, CA)
Assignee: Syntex Corporation (Panama, PM)
Application Number:05/558,988
Patent Claims: 1. A composition for treating inflammation, pain, pyrexia and pruritus in mammals which comprises a pharmaceutically acceptable non-toxic excipient and a therapeutically effective amount of a compound represented by the formula: ##STR9## where: R.sup.7 is alkyl having 1 to 6 carbon atoms, cycloalkyl having 3 to 7 carbon atoms, hydroxymethyl, alkoxymethyl having 2 to 7 carbon atoms, trifluoromethyl, vinyl, ethynyl, fluoro, chloro, hydroxy or a conventional hydrolyzable ester thereof derived from a hydrocarbon carboxylic acid having 1 to 12 carbon atoms, alkoxy having 1 to 6 carbon atoms, difluoromethoxy, alkoxymethyloxy, having 2 to 7 carbon atoms, alkylthiomethyloxy having 2 to 7 carbon atoms, alkylthio having 1 to 6 carbon atoms, difluoromethylthio, alkoxymethylthio having 2 to 7 carbon atoms, alkylthiomethylthio having 2 to 7 carbon atoms, formyl, carboxy, alkoxycarbonyl having 2 to 7 carbon atoms, acetyl, cyano or phenyl optionally p-monosubstituted with methyl, fluoro, chloro, hydroxy, methoxy or ethyl;

one of R.sup.10 and R.sup.11 is hydrogen, and the other is methyl, ethyl, difluoromethyl, fluoro or chloro, or R.sup.10 and R.sup.11 taken together are alkylidene, halomethylene or ethylene;

an alkyl ester of a compound of formula XIV derived from an alkanol having 1 to 12 carbon atoms; or a pharmaceutically acceptable addition salt thereof.

2. The composition according to claim 1 wherein said compound is 6-methoxy-2-naphthyl-.alpha.-methylacetic acid, an alkyl ester thereof derived from an alkanol having 1 to 12 carbon atoms, or a pharmaceutically acceptable addition salt thereof.

3. The composition according to claim 1 wherein said compound is 6-methoxy-2-naphthyl-.alpha.-methylacetic acid.

4. The composition according to claim 1 wherein said compound is d 6-methoxy-2-naphthyl-.alpha.-methylacetic acid, an alkyl ester thereof derived from an alkanol having 1 to 12 carbon atoms, or a pharmaceutically acceptable addition salt thereof.

5. The composition according to claim 1 wherein said compound is d 6-methoxy-2-naphthyl-.alpha.-methylacetic acid.

6. The composition according to claim 1 wherein said compound is 6-methylthio-2-naphthyl-.alpha.-methylacetic acid, an alkyl ester thereof derived from an alkanol having 1 to 12 carbon atoms, or a pharmaceutically acceptable addition salt thereof.

7. The composition according to claim 1 wherein said compound is 6-methylthio-2-naphthyl-.alpha.-methylacetic acid.

8. The composition of claim 1 wherein said compound is the sodium salt of 6-methoxy-2-naphthyl-.alpha.-methylacetic acid.

9. The composition of claim 1 wherein said compound is the sodium salt of d 6-methoxy-2-naphthyl-.alpha.-methylacetic acid.

10. The composition of claim 1 wherein said compound is methyl-6-methoxy-2-naphthyl-.alpha.-methylacetate.

11. A method for treating inflammation, pain, pyrexia and pruritus in mammals which comprises administering to a mammal suffering therefrom a therapeutically effective amount of a compound represented by the formula: ##STR10## where: R.sup.7 is alkyl having 1 to 6 carbon atoms, cycloalkyl having 3 to 7 carbon atoms, hydroxymethyl, alkoxymethyl having 2 to 7 carbon atoms, trifluoromethyl, vinyl, ethynyl, fluoro, chloro, hydroxy or a conventional hydrolyzable ester thereof derived from a hydrocarbon carboxylic acid having 1 to 12 carbon atoms, alkoxy having 1 to 6 carbon atoms, difluoromethoxy, alkoxymethyloxy having 2 to 7 carbon atoms, alkylthiomethyloxy having 2 to 7 carbon atoms, alkylthio having 1 to 6 carbon atoms, difluoromethylthio, alkoxymethylthio having 2 to 7 carbon atoms, alkylthiomethylthio having 2 to 7 carbon atoms, formyl, carboxy, alkoxycarbonyl having 2 to 7 carbon atoms, acetyl, cyano or phenyl optionally p-monosubstituted with methyl, fluoro, chloro, hydroxy, methoxy or ethyl;

one of R.sup.10 and R.sup.11 is hydrogen, and the other is methyl, ethyl, difluoromethyl, fluoro or chloro, or R.sup.10 and R.sup.11 taken together are alkylidene, halomethylene or ethylene;

an alkyl ester of a compound of formula XIV derived from an alkanol having 1 to 12 carbon atoms; or a pharmaceutically acceptable addition salt thereof.

12. The method according to claim 11 wherein said compound is 6-methoxy-2-naphthyl-.alpha.-methylacetic acid, an alkyl ester thereof derived from an alkanol having 1 to 12 carbon atoms, or a pharmaceutically acceptable addition salt thereof.

13. The method according to claim 11 wherein said compound is 6-methoxy-2-naphthyl-.alpha.-methylacetic acid.

14. The method according to claim 11 wherein said compound is 6-methylthio-2-naphthyl-.alpha.-methylacetic acid, an alkyl ester thereof derived from an alkanol having 1 to 12 carbon atoms, or a pharmaceutically acceptable addition salt thereof.

15. The method according to claim 11 wherein said compound is 6-methylthio-2-naphthyl-.alpha.-methylacetic acid.

16. The method according to claim 11 wherein said compound is d 6-methoxy-2-naphthyl-.alpha.-methylacetic acid, an alkyl ester thereof derived from an alkanol having 1 to 12 carbon atoms, or a pharmaceutically acceptable addition salt thereof.

17. The method according to claim 11 wherein said compound is d 6-methoxy-2-naphthyl-.alpha.-methylacetic acid.

18. The method according to claim 11 wherein said compound is 6-fluoro-2-naphthyl-.alpha.-methylacetic acid, an alkyl ester thereof derived from an alkanol having 1 to 12 carbon atoms, or a pharmaceutically acceptable addition salt thereof.

19. The method according to claim 11 wherein said compound is 6-chloro-2-naphthyl-.alpha.-methylacetic acid, an alkyl ester thereof derived from an alkanol having 1 to 12 carbon atoms, or a pharmaceutically acceptable addition salt thereof.

20. The method according to claim 11 wherein said compound is 6-methyl-2-naphthyl-.alpha.-methylacetic acid, an alkyl ester thereof derived from an alkanol having 1 to 12 carbon atoms, or a pharmaceutically acceptable addition salt thereof.

21. The method according to claim 11 wherein said compound is 6-trifluoromethyl-2-naphthyl-.alpha.-methylacetic acid, an alkyl ester thereof derived from an alkanol having 1 to 12 carbon atoms, or a pharmaceutically acceptable addition salt thereof.

22. The method according to claim 11 wherein said compound is 6-difluoromethoxy-2-naphthyl-.alpha.-methylacetic acid, an alkyl ester thereof derived from an alkanol having 1 to 12 carbon atoms, or a pharmaceutically acceptable addition salt thereof.

23. The method of claim 11 wherein said compound is the sodium salt of 6-methoxy-2-naphthyl-.alpha.-methylacetic acid.

24. The method of claim 11 wherein said compound is the sodium salt of d 6-methoxy-2-naphthyl-.alpha.-methylacetic acid.

25. The method of claim 11 wherein said compound is methyl 6-methoxy-2-naphthyl-.alpha.-methylacetate.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc